---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-24-085116"
form_type: "8-K"
ticker: null
cik: "0001845459"
company_name: "NKGen Biotech, Inc."
filed_at: "2024-10-03T23:59:59+00:00"
generated_at: "2026-05-30T21:40:19.492094+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Three NKGen Biotech directors Klowden, Park, Scott resign; board shrinks to 2

## Summary
- Michael Klowden, Sangwoo Park, and Kathleen Scott resigned as directors effective Sept 29, 2024, one-year anniversary of service.
- Resignations not due to any dispute with the company or board.
- Board size temporarily reduced from 5 to 2 directors; committees each reduced to 1 member.
- Board will seek new appointees within 180 days; discussions ongoing for Klowden and Scott reappointment.
- CEO Paul Y. Song thanked the departing directors for their service.

## SEC filing metadata
- accession: 0001213900-24-085116
- form_type: 8-K
- cik: 0001845459
- company_name: NKGen Biotech, Inc.
- filed_at: 2024-10-03T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1845459/000121390024085116/0001213900-24-085116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1845459/000121390024085116/ea0216077-8k_nkgen.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-24-085116
- JSON: https://secwatch.observer/filing/0001213900-24-085116.json
- Plain text: https://secwatch.observer/filing/0001213900-24-085116.txt

## Key facts
- Executive change
  Michael Klowden resigned as director at NKGen Biotech, Inc..
  - Action: resigned
  - Role: director
  source text: On September 28, Mr. Michael Klowden, Mr. Sangwoo Park and Ms. Kathleen Scott notified the Board of Directors of NKGen Biotech, Inc. (the “Company”) of their intentions to resign as directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845459/000121390024085116/0001213900-24-085116-index.htm
- Executive change
  Kathleen Scott resigned as director at NKGen Biotech, Inc..
  - Action: resigned
  - Role: director
  source text: On September 28, Mr. Michael Klowden, Mr. Sangwoo Park and Ms. Kathleen Scott notified the Board of Directors of NKGen Biotech, Inc. (the “Company”) of their intentions to resign as directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845459/000121390024085116/0001213900-24-085116-index.htm
- Executive change
  Sangwoo Park resigned as director at NKGen Biotech, Inc..
  - Action: resigned
  - Role: director
  source text: On September 28, Mr. Michael Klowden, Mr. Sangwoo Park and Ms. Kathleen Scott notified the Board of Directors of NKGen Biotech, Inc. (the “Company”) of their intentions to resign as directors of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1845459/000121390024085116/0001213900-24-085116-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.